Long-Acting Injectable (LAI) Antipsychotics Antipsychotic agents are often discontinued without provider consultation, leading to poorer outcomes and quality of life. Luckily, newer formulations are continually being developed to help address barriers to care and...
Topical corticosteroids are the mainstay for many skin conditions and disorders given their anti-inflammatory, antiproliferative, and immunosuppressive properties. They are available in a variety of strengths and dosage forms, including creams, ointments, lotions,...
Though antipsychotics are generally used for long-term treatment of psychiatric conditions, there are several instances where therapy may be stopped altogether. We outline several practice pearls and clinical considerations when determining if antipsychotic tapering...
ES is a 61-year-old female who is a resident in a long-term care facility. She has a history of drug abuse, early-onset dementia, GERD, chronic pain, and osteoarthritis. Her current medications include gabapentin 100 mg TID, donepezil 10 mg HS, omeprazole 20 mg in the...
On May 13, 2022, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM). Pathophysiology of Type 2 Diabetes Mellitus Incretins are the...